PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Carbonic Anhydrase 9 150 Target Target bFGF 9,327 1 0.00 -1.00 0.01 0.59
Stroke 146,992 Disease Target bFGF 9,327 57 0.00 -1.00 0.01 0.54
EPHB4 329 Target Target bFGF 9,327 2 0.00 -1.00 0.01 0.60
Endoglin 1,333 Target Target bFGF 9,327 8 0.00 -1.00 0.01 0.61
CD146 729 Target Target bFGF 9,327 4 0.00 -1.00 0.01 0.60
CA 72-4 184 Target Target bFGF 9,327 1 0.00 -1.00 0.01 0.59
DDR2 194 Target Target bFGF 9,327 1 0.00 -1.00 0.01 0.59
Non Small Cell Lung Cancer 28,563 Disease Target bFGF 9,327 47 0.00 -1.00 0.01 0.59
Diabetic Retinopathy 14,494 Disease Target bFGF 9,327 47 0.00 -1.00 0.01 0.62
Salivary Gland Cancer 202 Disease Target bFGF 9,327 1 0.00 -1.00 0.00 0.59
Osteoarthritis 36,287 Disease Target bFGF 9,327 46 0.00 -1.00 0.00 0.58
Multiple Myeloma 24,594 Disease Target bFGF 9,327 46 0.00 -1.00 0.00 0.60
Beta-Tubulin 4,870 Target Target bFGF 9,327 23 0.00 -1.00 0.00 0.62
Eotaxin 2,457 Target Target bFGF 9,327 11 0.00 -1.00 0.00 0.61
Benign Prostatic Hyperplasia 10,026 Disease Target bFGF 9,327 41 0.00 -1.00 0.00 0.63
Lung Carcinoma 13,423 Disease Target bFGF 9,327 40 0.00 -1.00 0.00 0.61
Cerebrovascular Disorder 237 Disease Target bFGF 9,327 1 0.00 -1.00 0.00 0.59
Fracture 111,575 Disease Target bFGF 9,327 38 0.00 -1.00 0.00 0.54
Cholesterol 182,390 Disease Target bFGF 9,327 36 0.00 -1.00 0.00 0.52
Tissue-Type Plasminogen Activator 5,020 Target Target bFGF 9,327 19 0.00 -1.00 0.00 0.62
EPHA2 532 Target Target bFGF 9,327 2 0.00 -1.00 0.00 0.59
Colon Cancer 30,064 Disease Target bFGF 9,327 34 0.00 -1.00 0.00 0.58
Pain 409,851 Disease Target bFGF 9,327 33 0.00 -1.00 0.00 0.50
ANGPTL4 289 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
CA 15-3 898 Target Target bFGF 9,327 3 0.00 -1.00 0.00 0.59
Ovarian Cancer 33,996 Disease Target bFGF 9,327 31 0.00 -1.00 0.00 0.57
Scars 12,872 Disease Target bFGF 9,327 30 0.00 -1.00 0.00 0.60
ERBB4 994 Target Target bFGF 9,327 3 0.00 -1.00 0.00 0.59
Bladder Cancer 21,509 Disease Target bFGF 9,327 28 0.00 -1.00 0.00 0.58
CCL5 2,002 Target Target bFGF 9,327 6 0.00 -1.00 0.00 0.60
CXCL16 341 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
CD4 112,219 Target Target bFGF 9,327 27 0.00 -1.00 0.00 0.53
Osteoporosis 46,215 Disease Target bFGF 9,327 27 0.00 -1.00 0.00 0.55
EPHA4 357 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
Burns 26,206 Disease Target bFGF 9,327 24 0.00 -1.00 0.00 0.57
Herniated Discs 393 Disease Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
CD68 6,424 Target Target bFGF 9,327 15 0.00 -1.00 0.00 0.60
Shock 134,031 Disease Target bFGF 9,327 21 0.00 -1.00 0.00 0.51
Phospholipase A2 13,400 Target Target bFGF 9,327 21 0.00 -1.00 0.00 0.59
N-Type Calcium Channel 453 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.57
Hemorrhage 100,979 Disease Target bFGF 9,327 20 0.00 -1.00 0.00 0.52
Androgen Receptor 12,918 Target Target bFGF 9,327 20 0.00 -1.00 0.00 0.59
CXCL9 1,016 Target Target bFGF 9,327 2 0.00 -1.00 0.00 0.58
Sphingomyelinase 3,060 Target Target bFGF 9,327 6 0.00 -1.00 0.00 0.59
ApoE2 517 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.57
Chronic Lymphocytic Leukemia 11,642 Disease Target bFGF 9,327 18 0.00 -1.00 0.00 0.59
CXCL11 526 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.57
ETS1 539 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.57
Angiotensin Converting Enzyme 31,674 Target Target bFGF 9,327 17 0.00 -1.00 0.00 0.55